OUTCOMES AFTER TRANSTHORACIC, PERIPHERAL VASCULAR AND TRANSFEMORAL TRANSCATHETER AORTIC VALVE IMPLANTATION: A PROPENSITY ANALYSIS FROM FRANCE TAVI REGISTRY

According to PARTNER 2 (2016), Transcatheter Aortic Valve Replacement (TAVR) is non inferior to surgery in intermediate risk patient. Furthermore, TAVR through a transfemoral access might be superior to surgery (second cohort, not designed for superiority) while TAVR through other access sites,